NCT04910919

Brief Summary

Tonsillectomy is one of the most common surgeries performed in the United States, with over half a million performed annually in children younger than 15 years of age. Postoperative pain is one of the most common clinical problems and may lead to poor intake, dehydration, and weight loss. Management of postoperative pain is often challenging and results in additional medical costs due to unplanned emergency room visits. Opioids such as codeine are commonly prescribed for pain control, however in 2013 the Food \& Drug Administration issued a black box warning for the use of codeine in post-tonsillectomy pediatric patients. The American Academy of Otolaryngology-Head and Neck Surgery recommends the use of acetaminophen and ibuprofen to successfully manage postoperative pain. With an extended recovery period, often longer than 7 days, alternative measures to reduce postoperative pain are needed. Honey has been proven to possess antibacterial and anti-inflammatory properties. This intervention will evaluate the effect of Tylenol, ibuprofen with honey on children's postoperative pain and nausea following tonsillectomy surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 2, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

March 1, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

July 7, 2022

Status Verified

October 1, 2021

Enrollment Period

4 months

First QC Date

May 27, 2021

Last Update Submit

July 1, 2022

Conditions

Keywords

honeypediatricspost-operativepainnauseatonsillectomycomplimentary and alternative medicine

Outcome Measures

Primary Outcomes (3)

  • Numeric value of post-operative pain measured by FACES pain scale

    The post-operative pain is measured by the self-reported FACES pain scale. The range of scores is from 0-10. 0 (smiling face = no pain) and 10 (crying face) = worst pain ever. This scale is used by patients who are developmentally able, ages 5-9.

    Post-operative day 0 to post-operative day 5.

  • Numeric value of post-operative pain measured by Visual Analog Scale (VAS) pain scale

    The VAS uses a horizontal 10cm line with the extremes of "no pain at all" and "worst pain imaginable". The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. This scale is used by patients who are developmentally able, ages 10-17.

    Post-operative day 0 to post-operative day 5.

  • Numeric value of post-operative nausea measured by Baxter Animated Retching Faces (BARF) scale

    Baxter Animated Retching Faces (BARF) scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more nausea).

    Post-operative day 0 to post-operative day 5.

Secondary Outcomes (1)

  • Beliefs and receptiveness of patient families on pain management measured with the catastrophizing scale

    Baseline to 6 weeks

Study Arms (2)

Standard of Care

ACTIVE COMPARATOR

The first 50 participants will receive treatment as usual (alternating weight-based dosing of acetaminophen and ibuprofen with a PRN three-day supply of opioid analgesic).

Other: Standard of Care

Honey Intervention

EXPERIMENTAL

Participants 51 - 100 will receive the standard of care treatment as usual plus 1 tsp of honey with every dose of acetaminophen.

Dietary Supplement: HoneyOther: Standard of Care

Interventions

HoneyDIETARY_SUPPLEMENT

Participants 51 - 100 will receive the standard of care treatment as usual plus 1 tsp of honey with every dose of acetaminophen.

Honey Intervention

The first 50 participants will receive treatment as usual (alternating weight-based dosing of acetaminophen and ibuprofen with a PRN three-day supply of opioid analgesic).

Honey InterventionStandard of Care

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • english speaking
  • children ages 5-17 years

You may not qualify if:

  • any child with a genetic syndrome or developmental disability
  • allergies to honey
  • non-english speaking families

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monroe Carell Jr. Children's Hospital at Vanderbilt

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

PainNausea

Interventions

HoneyStandard of Care

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, Digestive

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Patti Runyan, DNP

    Monroe Carell Jr. Children's Hospital at Vanderbilt

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Administrative Director

Study Record Dates

First Submitted

May 27, 2021

First Posted

June 2, 2021

Study Start

March 1, 2022

Primary Completion

July 1, 2022

Study Completion

July 1, 2022

Last Updated

July 7, 2022

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations